Paul Bergmans

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

Henk W. Berendse, Jan Booij, Chantal M. J. E. Francot et al. · Annals of Neurology · 2001 · 297 citations

Life Sciences, Neurology, Neuroscience +17

Loss of olfaction in de novo and treated Parkinson's disease: Possible implications for early diagnosis

Gerrit Tissingh, Henk W. Berendse, Paul Bergmans et al. · Movement Disorders · 2001 · 263 citations

Life Sciences, Neurology, Neuroscience +17

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

Jan Booij, Jan B. A. Habraken, Paul Bergmans et al. · PubMed · 1998 · 182 citations

Medicine, Neuroscience, Nuclear Medicine +16

Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease

E.Ch. Wolters, E.N.H. Jansen, H. Tuynman-Qua et al. · Neurology · 1996 · 177 citations

Medicine, Pharmacology, Pharmacotherapy +17

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

Hans‐Christoph Diener, R. Agosti, Gianni Allais et al. · The Lancet Neurology · 2007 · 163 citations

Pharmacy, Neurology, Pharmacotherapy +10